Top Industry Leaders in the Wolff Parkinson White Syndrome Market
Latest Wolff Parkinson White syndrome Companies Updates:
Abbott (US): Announced FDA approval for its new Carto 3™ System with Surround Sound technology in July 2023, potentially offering improved mapping and navigation capabilities during ablation procedures, which are sometimes used to treat WPW.
Boston Scientific (US): Received CE Mark approval for its TactiCath® Contact Force Sensing Catheter in September 2023, which may enhance safety and efficacy of catheter ablation procedures, including those for WPW.
Biosense Webster (US): Highlighted its CARTOS® System's role in complex cardiac ablation procedures, including WPW, in its recent clinical study presentations.
CardioNet (US): Launched its new Remote Patient Monitoring (RPM) platform for patients with arrhythmias, including those with WPW, in October 2023, enabling continuous monitoring and early detection of potential complications.
Philips (Netherlands): Showcased its advanced ECG devices and AI-powered analysis tools for accurate diagnosis of arrhythmias, including WPW, at its recent medical conference participation.
List of Wolff Parkinson White syndrome Key companies in the market:
- AngioDynamics
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical, LLC
- Abbott
- GlaxoSmithKline LLC
- Teva Pharmaceutical Industries
- Sanofi S.A.
- Novartis International AG